Rothschild & Co Asset Management US’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$515K Sell
1,960
-50
-2% -$13.4K 0.01% 251
2022
Q3
$453K Hold
2,010
0.01% 254
2022
Q2
$489K Hold
2,010
0.01% 260
2022
Q1
$486K Sell
2,010
-10
-0.5% -$2.3K 0.01% 262
2021
Q4
$454K Hold
2,020
0.01% 269
2021
Q3
$430K Sell
2,020
-80
-4% -$18.4K 0.01% 268
2021
Q2
$512K Hold
2,100
0.01% 264
2021
Q1
$523K Sell
2,100
-30
-1% -$7.16K 0.01% 268
2020
Q4
$490K Hold
2,130
0.01% 280
2020
Q3
$541K Buy
2,130
+170
+9% +$42.1K 0.01% 290
2020
Q2
$462K Buy
1,960
+360
+23% +$82.1K 0.01% 305
2020
Q1
$324K Hold
1,600
0.01% 319
2019
Q4
$386K Sell
1,600
-50
-3% -$11K ﹤0.01% 337
2019
Q3
$319K Sell
1,650
-50
-3% -$9.6K ﹤0.01% 342
2019
Q2
$313K Hold
1,700
﹤0.01% 345
2019
Q1
$323K Sell
1,700
-2,206
-56% -$421K ﹤0.01% 357
2018
Q4
$760K Sell
3,906
-8
-0.2% -$1.56K 0.01% 360
2018
Q3
$811K Sell
3,914
-101
-3% -$19.9K 0.01% 358
2018
Q2
$741K Sell
4,015
-698
-15% -$123K 0.01% 364
2018
Q1
$803K Sell
4,713
-139,904
-97% -$25.7M 0.01% 344
2017
Q4
$25.1M Sell
144,617
-1,665
-1% -$295K 0.27% 161
2017
Q3
$27.3M Sell
146,282
-159,998
-52% -$28.3M 0.3% 143
2017
Q2
$52.8M Sell
306,280
-7,692
-2% -$1.25M 0.6% 42
2017
Q1
$51.5M Sell
313,972
-1,083
-0.3% -$180K 0.59% 39
2016
Q4
$46.1M Buy
315,055
+101,645
+48% +$15.3M 0.59% 36
2016
Q3
$35.6M Sell
213,410
-12,058
-5% -$2.04M 0.61% 27
2016
Q2
$34.3M Sell
225,468
-20,044
-8% -$3.12M 0.62% 31
2016
Q1
$36.8M Sell
245,512
-73,645
-23% -$10.9M 0.69% 36
2015
Q4
$51.8M Buy
319,157
+61,766
+24% +$9.71M 0.94% 14
2015
Q3
$35.6M Buy
257,391
+7,375
+3% +$1.16M 0.7% 32
2015
Q2
$38.4M Sell
250,016
-29,211
-10% -$4.68M 0.71% 37
2015
Q1
$44.6M Sell
279,227
-28,006
-9% -$4.41M 0.85% 19
2014
Q4
$49.4M Sell
307,233
-30,332
-9% -$4.73M 0.99% 16
2014
Q3
$47.4M Buy
337,565
+167,539
+99% +$21.9M 1.01% 19
2014
Q2
$20.1M Buy
170,026
+6,505
+4% +$753K 0.41% 65
2014
Q1
$20.2M Buy
163,521
+157,235
+2,501% +$19.1M 0.45% 61
2013
Q4
$717K Sell
6,286
-60
-0.9% -$6.83K 0.02% 357
2013
Q3
$710K Sell
6,346
-110
-2% -$11.9K 0.02% 351
2013
Q2
$637K Buy
+6,456
New +$670K 0.01% 354

Other funds holding AMGN

Rothschild & Co Asset Management US's AMGN Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its Amgen (AMGN) stake by 2.5% in Q4 2022, selling an estimated $13.4K and leaving 1,960 shares worth $515K. The position accounts for 0.01% of the portfolio, ranked #251.

Rothschild & Co Asset Management US first reported a position in AMGN in Q2 2013 and has held it in 39 quarters since. The position peaked at $52.8M in Q2 2017. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Rothschild & Co Asset Management US held 1,960 shares of Amgen worth $515K as of Q4 2022.
  • Rothschild & Co Asset Management US sold 50 Amgen shares in Q4 2022, an estimated $13.4K.
  • Amgen made up 0.01% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #251 holding.
  • Rothschild & Co Asset Management US first reported a position in Amgen in Q2 2013 and has held it in 39 quarters since.
  • Rothschild & Co Asset Management US's Amgen position peaked at $52.8M in Q2 2017.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.